Mate surely you have said your piece and now its time to move...

Mate surely you have said your piece and now its time to move on. We get it you think its overvalued because you don't understand the valuation of a company based on potential future earnings. Many people have done their own research and have taken a calculated risk based on the potential of RAP. It might shock you but that's what investing is, a calculated risk. The successful clinical trials and Australian and European regulatory approval demonstrate the company is on the right path. A tick from the FDA and realisation of commercial agreements are the next major milestones. If you don't understand this maybe do some personal research, or better yet just don't comment.